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ABSTRACT

ARTICLE HISTORY

Background: Clinicians commonly advise patients to look away from the needle during
vaccinations; however, this recommendation is not evidence based.
Aim: The aim of this study was to determine whether looking at the needle versus looking
away affects pain and fear during vaccinations in adults.
Methods: This was a pilot randomized two-group parallel trial with university students receiving influenza vaccinations. Participants were stratified according to their initial needle-looking
preference and randomly assigned to either look at versus away from the needle. Participants
self-reported their pain and fear during vaccination.
Results: Of the 184 subjects who agreed to participate, 160 were enrolled; 66% were female. A
three-way analysis of variance (ANOVA; Looking allocation assignment × Looking preference ×
Sex) revealed a significant main effect of looking allocation assignment on fear (P = 0.025);
those who were randomized to look had higher fear scores than those who were randomized
to look away. There was also a significant main effect of looking preference on fear (P < 0.001);
those who preferred to look away had higher fear scores than those who preferred to look.
There was no evidence of an effect of looking allocation assignment or looking preference on
pain. There was a significant main effect of sex on fear and pain, with females reporting higher
pain and fear scores than males (P = 0.017 and P = 0.001, respectively). There were no
significant interactions.
Conclusion: These preliminary findings suggest that advising individuals to look away from
the needle reduces fear. A larger trial including more individuals and a different population is
recommended to confirm the results.
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RÉSUMÉ

Contexte: Les cliniciens conseillent habituellement aux patients de ne pas regarder l’aiguille
pendant la vaccination; toutefois, cette recommandation ne s’appuie pas sur des données
probantes.
But: Déterminer si le fait de regarder l’aiguille ou de ne pas la regarder influence la douleur et
la peur pendant la vaccination chez les adultes.
Méthodes: Un essai pilote randomisé avec deux groupes parallèles a été mené auprès
d’étudiants universitaires devant recevoir un vaccin contre l’influenza. Les participants ont
été stratifiés selon leur préférence initiale pour regarder l’aiguille ou ne pas la regarder. Ils ont
ensuite été répartis de façon aléatoire entre un groupe assigné à regarder l’aiguille et un
groupe assigné à ne pas la regarder. Les participants ont autodéclaré leur douleur et leur peur
pendant la vaccination.
Résultats: Parmi les 184 sujets ayant accepté de participer à l’étude, 160 y ont été inscrits,
dont 66 % de femmes. Une ANOVA à trois critères (ne pas regarder l’aiguille x préférence
pour regarder ou ne pas regarder l’aiguille x sexe) a révélé un effet significatif de l’assignation à regarder l’aiguille sur la peur (p = 0,025); ceux qui ont été randomisés pour regarder
l’aiguille ont obtenu un score plus élevé en ce qui concerne la peur que ceux qui ont été
randomisés pour ne pas la regarder. Un effet significatif de la préférence pour regarder sur la
peur également été observé (p < 0,001) : ceux qui préféraient ne pas regarder l’aiguille ont
obtenu un score plus élevé en ce qui concerne la peur que ceux qui préféraient regarder.
Aucune preuve d’un effet de l’assignation à regarder ou de la préférence pour regarder sur la
douleur n’a été relevée. Un effet significatif du sexe sur la peur et sur la douleur a été
observé, les femmes ayant déclaré des niveaux de douleur et de peur plus élevés que les
hommes (p = 0,017 et p = 0,001, respectivement). Aucune interaction significative n’a été
observée.
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Conclusion: Ces résultats préliminaires suggèrent que le fait de conseiller aux personnes de ne
pas regarder l’aiguille réduit la peur. Un essai plus vaste mené auprès d’un plus grand nombre
d’individus et d’une population différente est recommandé afin de confirmer les résultats.
Trial Registration No. NCT02937428.

Introduction
Vaccinations prevent morbidity and mortality from infectious diseases.1 However, approximately 25% of adults are
afraid of needles, with anticipated needle pain being a
significant source of this fear.2 This potential for pain
and fear presents an important barrier to vaccination
uptake, resulting in one out of 12 adults either delaying
or refusing vaccinations entirely.3,4 Mitigating pain and
fear may lead to increased vaccination compliance and
favorably impact long-term health outcomes, for both
individuals and communities.5–9 Many evidence-based
strategies are available to help reduce needle pain and
fear and combat noncompliance, but they are underutilized in clinical practice (e.g., topical anesthetics).8 In
addition, the majority of these interventions are targeted
toward children.9–12 There is a need to find feasible interventions for adults undergoing vaccination.
One simple intervention used by some clinicians to
reduce fear and pain involves advising individuals to look
away from the needle during injection.10 To our knowledge, there are no randomized trials that have determined
the effectiveness of this intervention with respect to reducing fear or pain during vaccination. In four nonclinical
and one clinical observational study performed to date,
conflicting results were obtained for self-reported pain
after asking healthy adults to either look at versus look
away during a painful stimulus.10,13–16 Higher pain scores
during looking have been explained as possibly due to
increasing autonomic nervous system activity in the
individual.13,14 Conversely, lower pain scores during looking have been explained as possibly preventing an individual’s imagination from conjuring up a more traumatic
experience than reality.10 This evidence base did not
include vaccinations. The nonclinical studies incorporated
pain ratings from electrical, laser, and thermal stimuli,
whereas the clinical study examined venipuncture.10,13–16
The effects of looking at or looking away from different
medical procedures involving needles may have different
fear- and pain-inducing components.9 It is important to
explore the effects of this intervention during vaccinations
specifically.
The pain and fear experience may be influenced by
personal needle-looking preferences. In the only observational study carried out in a clinical setting, 73% of
192 adult participants spontaneously looked away during

venipuncture. These participants reported higher pain
scores than those who preferred to look at the needle.10
According to the author, it is possible that those who
naturally look away have higher pain scores because the
propensity to look away may be a marker of low pain
tolerance.10 In those who prefer to look, repeated pairings of looking at the needle during needle procedures
may have a desensitizing effect. A mismatch between
personal preference and clinician recommendation may
negatively impact the person’s pain and fear experience.
It is possible that an individual’s preference to look at
or look away from noxious stimuli is based on underlying
coping style and may impact an individual’s pain and fear
experience. The literature on coping is complex, with
numerous ways to conceptualize different strategies.17–19
One conceptualization distinguishes between sensitizers
versus repressors, who are characterized by approach versus avoidance behaviors, respectively.18,19 Sensitizers tend
to actively seek out information concerning the nature of
the stressful situation, whereas repressors avoid information or use coping strategies such as denial.18,19 In the
context of needle procedures, sensitizers would prefer to
watch the needle and learn about each step of the procedure, whereas repressors would prefer to look away from
the procedure and/or focus on something else. The success of these coping strategies likely depends on what is
being attended to/what sensitizers are focusing on (e.g.,
sensations vs. emotions).19 To date, however, no research
has examined the complex interplay between clinical
recommendations for looking and one’s own looking
preference as coping strategies and how this interaction
may have an impact on pain and fear perception.
We undertook a pilot randomized trial to explore
the impact of being instructed to look at the needle to
reduce pain and fear versus looking away, while
accounting for looking preferences of individuals. The
specific objectives were to examine feasibility, acceptability, and fidelity and estimate effects to inform a
larger randomized control trial.

Materials and methods
Population and setting
We conducted a pilot randomized, two-group, parallel,
open trial. The setting was the University of Toronto
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Health and Wellness Centre. Eligible participants
included any student (18+ years old) enrolled in the
undergraduate and graduate programs at the Leslie Dan
Faculty of Pharmacy who consented to (1) receiving
influenza vaccinations and (2) being randomized to
either look at the needle or look away from it during
vaccination. Study data collection was conducted
between October 24, 2016, and January 5, 2017.
Materials
A questionnaire administered by a research assistant
(RA) was used to collect demographic information
(e.g., sex, age, ethnicity) and looking preference.
Looking preference was ascertained using the question,
“When getting injections, do you usually prefer to look
at or look away from the needle?”
Postvaccination, an RA administered two 11-point
Verbal Numerical Rating Scales (VNRS)8,20 to collect
pain and fear scores. The following two questions were
asked: (1) “On a scale of 0 to 10, where 0 is no pain, and 10
is the most pain possible, how would you rate your pain
during the needle?” and (2) “On a scale of 0 to 10, where 0
is no fear, and 10 is the most fear possible, how fearful were
you during the needle?” In addition, postvaccination, participants reported their needle-looking preferences for
future vaccinations. This was based on responses of the
participants to the question, “What would you prefer to do
for your future vaccinations? [look, look away, no preference].” The postvaccination questionnaire also included a
compliance checkbox whereby an RA checked off either
“yes” or “no” to the question: “Was the participant compliant with the study instructions?”
Consenting process
Posters, e-mails, and class announcements were used to
introduce the study to all registered students (total
population N = 1109). On-site recruitment was conducted for 3 weeks (from October 3, 2016, to October
21, 2016) on weekdays from 9 AM to 5 PM, whereby
interested individuals approached the study coordinator to enroll. Written informed consent was obtained
from all participants. As per routine practice, appointments were scheduled for vaccinations. A confirmation
e-mail reminder was sent. The study was approved by
the University Research Ethics Board. The study was
registered on www.clinicaltrials.gov (NCT02937428).
Randomization and allocation concealment
An RA not directly associated with trial execution created a randomization code using a computerized
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random number generator. A separate code was used
according to individual looking preference; that is,
patients were stratified based on baseline preference to
either look at or look away from the needle. Within
each stratum, individuals were randomized to either
look at or look away from the needle during the vaccine
injection using a 1:1 allocation ratio. Thus, there were
four study groups: (1) prefer to look away and randomized to look; (2) prefer to look away and randomized
to look away; (3) prefer to look and randomized to
look; and (4) prefer to look and randomized to look
away. Sequentially numbered opaque sealed envelopes
were prepared for each stratum. This RA did not have
any other involvement in the trial. On the day of the
vaccination, a different RA opened the next envelope to
reveal the allocation group of the participant immediately before vaccination.
Study procedures
Two registered nurses at the Health and Wellness Centre
administered all vaccine injections. Both nurses underwent training prior to study execution to ensure understanding of the protocol and consistency in injection
techniques used for vaccinations. Training included
scripts for interactions with participants (described
further below). Three RAs were involved in data collection; one was responsible for greeting and registering
participants, the second collected baseline information
(demographics and needle-looking preference) and
opened the concealed envelope containing the allocation
group, and the third collected postvaccination data, which
included pain and fear ratings, compliance with the intervention, and future needle-looking preference.
All vaccinations occurred in private rooms with separate
entrances and exits. The nurse provided standard information about the influenza vaccine and asked the participant
questions in accordance to usual practice at the clinic. All
participants sat upright on a chair, with their elbow resting
on the armrest. The participant’s nondominant arm was
swabbed with alcohol (70% isopropyl alcohol, Healthcare,
Medical Mart, Mississauga, Ontario, Canada). The nurse
asked the participant to “relax the arm and let it go all loose
and jiggly.” Then the participant was asked to “look directly
at the needle” or “look away from the needle in the other
direction,” according to group allocation. The nurse said,
“Here I go . . .” right before injecting the vaccine. All
participants received 0.5 mL of Fluviral (Sanofi,
GlaxoSmithKline, Mississauga, Ontario, Canada) intramuscularly, without prior aspiration, using a 0.5 mm ×
25 mm needle (BD Eclipse, Becton, Dickinson and
Company, Rantoul, Illinois, USA). After injection, a band
aid was applied and the nurse said, “We’re all done.” The
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RA asked participants about their level of pain and fear
during the vaccination. Compliance with the intervention
was noted and participants were asked about their future
needle-looking preferences.
Study outcomes
Primary outcomes
● Pain: Self-reported pain was assessed using an 11point VNRS,17 where 0 = no pain and 10 = most
pain possible immediately after the vaccination
(<5 min).
● Fear: Self-reported fear was assessed using an 11point VNRS,8 where 0 = no fear and 10 = most
fear possible immediately after the vaccination
(<5 min).
Secondary outcomes
● Feasibility: The first feasibility criterion was
achieving a minimum overall recruitment rate of
15% (n = 166) over a 6- to 8-week period (study
timeline). This was based on an estimate of 30% of
the eligible population (N = 1109) getting vaccinated and a 50% enrollment rate. The second
criteria for feasibility was an assumption of an
equal split (50:50) in the number of people who
preferred to look at or away from the needle at
baseline (to allow for an equal number of participants in each stratum).
● Acceptability: Acceptability of the intervention
was based on three criteria: First, a rate of >75%
of participants completing the trial; second, a
duration of appointment of <15 min; and third,
the looking preference of participants for future
vaccinations.
● Fidelity: Fidelity of the intervention was based on
a rate of >75% of participants being compliant
with the instruction to look at the needle or look
away during the vaccination.

Sample size calculation and statistical analysis
In the absence of any prior data to guide effect size
estimates, the sample size was arbitrarily set to n = 40
per group (total, n = 80), according to Hertzog.21
Because two strata were included, the sample size was
doubled (i.e., n = 80 × two strata, or total, n = 160),
assuming a 50:50 split.
Demographic characteristics (i.e. age, sex, ethnicity)
were compared between groups using a t-test and χ2

test, as appropriate. Two three-way analyses of variance
(ANOVAs; Looking allocation assignment × Looking
preference × Sex) were used to examine pain and fear
scores. Looking allocation assignment included two
levels (randomized to look at versus randomized to
look away). Similarly, looking preference included two
levels (participant preference to look at versus preference
to look away), and sex included two levels (male versus
female). Interactions were removed from the model if
nonsignificant. Sex was included as an independent factor in the model because previous studies demonstrate
sex differences in both pain and fear, with females
reporting more pain and fear than males.19–22 Q-Q
plots were examined to rule out departure from normality in the residuals of the model. There were no observable departures from normality. The Pearson
correlation coefficient was used to examine the relationship between pain and fear scores during vaccination.

Results
Participant flow
Data collection was conducted between October 24,
2016, and January 5, 2017. Altogether, 184 were
enrolled, of whom 24 (13%) did not attend the appointment, leaving 160 participants. Fifty-five (34%) selfidentified at baseline as preferring to look at the needle;
the remaining 105 (66%) preferred to look away from
the needle. Figure 1 shows the participant flow during
the trial.
Participant characteristics
There were no statistically significant differences
(P > 0.05) in demographic characteristics among the
four groups (Table 1).
Primary outcomes
Table 2 presents the means and standard deviations of the
pain ratings of males and females, immediately following
the vaccination. There were no significant interactions.
The analysis demonstrated no evidence of an effect of
looking allocation assignment on pain: randomized to
look (n = 80, mean = 3.09, SD = 1.93), versus randomized
to look away (n = 79, mean = 2.95, SD = 2.02), F
(1,55) = 0.33, P = 0.567. There was no evidence of an
effect of looking preference on pain: preference to look
(n = 55, mean = 2.58, SD = 1.67) versus preference to look
away (n = 104, mean = 3.25, SD = 2.08), F(1,155) = 2.57,
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Figure 1. CONSORT participant flow diagram.

Table 1. Participant characteristics (n = 160).a

Age, years
Sex, female
Ethnicity,
Asian

Preference to look,
randomized to look
(n = 28)
23.8 (3.8)
14 (50)
23 (82)

Preference to look,
randomized to look away
(n = 27)
23.7 (2.2)
17 (63)
16 (59)

Preference to look away,
randomized to look
(n = 52)
23.1 (1.8)
38 (73)
37 (71)

Preference to look away,
randomized to look away
(n = 53)
23.2 (2.1)
37 (70)c
31 (58)

P
valueb
0.487
0.194
0.086

a

Values are mean (SD) or frequency (%).
Chi square test or ANOVA.
c
Missing data (n = 1).
b

Table 2. Verbal Numerical Rating Scalea pain scores of males
and females.b
Randomized to Randomized to look
look
away
Males
Preference to look
Preference to look
away
Column mean (SD)
Females
Preference to look
Preference to look
away
Column mean (SD)

Row mean
(SD)

(n = 14)
2.25 (1.72)
(n = 14)
2.54 (2.10)
(n = 28)
2.39 (1.89)

(n = 10)
2.0 (1.49)
(n = 16)
2.13 (1.86)
(n = 26)
2.08 (1.70)

(n = 24)
2.15 (1.60)
(n = 30)
2.32 (1.95)

(n = 14)
2.71 (1.59)
(n = 38)
3.75 (1.90)
(n = 52)
3.47 (1.86)

(n = 17)
3.09 (1.75)
(n = 36)
3.51 (2.17)
(n = 53)
3.38 (2.04)

(n = 31)
2.92 (1.66)
(n = 74)
3.64 (1.97)

Scores range from 0 to 10 (0 = no pain, 10 = most pain possible) immediately postvaccination.
b
Values are mean (SD). General Linear Model (GLM) procedure three-way ANOVA
results for pain: There was a significant main effect of sex, F(1,155) = 12.08,
P = 0.0007, not strata, F(1,155) = 2.57, P = 0.111, or randomization (looking
allocation assignment), F(1,155) = 0.33, P = 0.567; see text for details.
a

P = 0.111. There was, however, a significant effect of sex
on pain: females (n = 105, mean = 3.42, SD = 1.94) versus
males (n = 54, mean = 2.24, SD = 1.79), F(1,155) = 12.08,
P = 0.0007.
Table 3 presents fear ratings of males and females.
There were no significant interactions. There was a
significant main effect of looking allocation assignment
on fear: randomized to look (n = 80, mean = 2.81, SD =
2.3) versus randomized to look away (n = 79, mean =
2.06, SD = 2.3), F(1,155) = 5.14, P = 0.025. There was a
significant main effect of looking preference: preference to look (n = 55, mean = 1.55, SD = 2.3) versus
preference to look away (n = 104, mean = 2.91, SD =
2.3), F(1,155) = 11.79, P = 0.0008. There was a significant main effect of sex on fear: females (n = 105, mean =
2.79, SD = 2.3) versus males (n = 54, mean = 1.75, SD =
2.3), F(1,155) = 5.78, P = 0.017.
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Table 3. Verbal Numerical Rating Scalea fear scores of males
and females.b
Males
Preference to look
Preference to look
away
Column mean (SD)
Females
Preference to look
Preference to look
away
Column mean
(SD)

Randomized to
look

Randomized to
look away

Row mean
(SD)

(n = 14)
1.25 (1.01)
(n = 14)
2.36 (1.69)
(n = 28)
1.8 (1.48)

(n = 10)
1.65 (1.25)
(n = 16)
1.72 (1.71)
(n = 26)
1.69 (1.52)

(n = 24)
1.42 (1.11)
(n = 30)
2.02 (1.70)

(n = 14)
1.64 (2.5)
(n = 38)
3.97 (2.65)
(n = 52)
3.35 (2.79)

(n = 17)
1.65 (1.66)
(n = 36)
2.53 (2.34)
(n = 53)
2.25 (2.17)

(n = 31)
1.65 (2.04)
(n = 74)
3.27 (2.59)

Scores range from 0 to 10 (0 = no fear, 10 = most fear possible) immediately postvaccination.
b
Values are mean (SD). GLM procedure three-way ANOVA results for fear:
There was a significant main effect for sex, F(1,155) = 5.78, P = 0.017,
strata (looking preference), F(1,155) = 11.79, P = 0.0008, and randomization (looking allocation assignment), F(1,155) = 5.14, P = 0.025; see text
for details.
a

The Pearson correlation coefficient between pain
and fear scores was 0.60 (P < 0.0001).
Secondary outcomes
●

Feasibility: Altogether, 184 participants were
enrolled; the recruitment rate was 17%. The ratio
of people who had a baseline preference to look at
the needle versus look away from the needle was
66:34 in the sample.
● Acceptability: All (100%) of participants who were
randomized stayed in the study (i.e., none of the
participants withdrew). The mean (SD) time taken
for the entire procedure from baseline questions, to
vaccination procedure, to postvaccination questions
was 11 min 28 s (±2 min 40 s). Altogether, 74.4% of
participants maintained their original looking/not
looking preference for future vaccinations.
● Fidelity: One participant (0.6%) was noncompliant
with the intervention. The participant had a baseline preference to look away and was randomized
to look at the needle. This individual looked away
during injection.

Discussion
To our knowledge, this is the first randomized trial to
examine the impact of looking at the needle versus
looking away during vaccination on pain and fear in
adults. Feasibility, acceptability, and fidelity of the
intervention were demonstrated. Looking at the needle
versus looking away did not have a significant impact

on pain but did significantly impact fear, with those
who were told to look at the needle reporting significantly more fear. Similarly, those who initially preferred
to look away reported significantly more fear. Females
in our study reported significantly more pain and fear
than males. There was no evidence of any interactions
between the factors evaluated. Thus, there was no evidence that a mismatch between initial preference to
look or not look and randomization group impacts
pain or fear.
Assessing an individual’s fear during vaccination is
important because fear can increase pain perception.9
Concerns about fear and pain can also negatively impact
future vaccination compliance.9 Of note, reported pain
did not vary with looking behavior in the present study,
but reported fear did. It is possible that the fear experienced by participants was not limited to the fear of pain
but included apprehensions about other aspects of the
procedure.9 It is also possible that no effect was observed
for pain due to the small sample size, relatively low levels
of fear and pain in our study population, and the specific
procedure and vaccine used.9,10 Future studies are
recommended that examine different populations, procedures, and vaccines.
Studies have shown that females report higher pain and
fear than males.22–25 Differences in physiological responses
to pain and fear have been observed in males and females,
including pupil dilation, brain scans, and other neurological
parameters.22,23 Explanations may include psychosocial
factors, hormonal factors, genetic factors, or a combination
of all of these.23 For instance, it is possible that males are
conditioned to report less pain and fear due to differences in
reinforcement of expressions of pain and fear in
childhood.23–25 The results of this study are consistent
with this literature—females reported more pain and fear
during vaccination than their male counterparts.
The intervention evaluated in the present study
demonstrated high feasibility, acceptability, and fidelity.
The recruitment rate met our a priori criterion for
demonstrating that the study was feasible because we
met our recruitment rate of 15% within a 3-week period (faster than the anticipated 6–8 weeks). To account
for the 24 participants who did not attend their
appointments, additional participants were enrolled
for an additional recruitment week. This suggests that
enrolling participants at the proposed rate for a similar
study in the future is feasible. The ratio of people who
had baseline preference to look at the needle versus
look away was anticipated to be 50:50; however, the
actual split was 34:66, which precluded us from reaching the desired sample size for people with a baseline
preference to look at the needle. An uneven split was
also reported in a previous observational study by
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Vijayan et al.10 that assessed spontaneous behavior, in
which the ratio was 27:73. Future studies will need to
account for this difference in recruitment rates if both
needle-looking preferences are to be included.
The trial was deemed acceptable based on the low
attrition rate (i.e., no dropouts/withdrawals once randomized) and short duration required to implement
the intervention (approximately five to six more minutes than usual practice, including all study procedures)
per participant. The average time for vaccination
including the study procedures was just over 10 min,
approximately double the time usually taken in the
clinic. This additional time can be built into a future
trial. Though compliant with the intervention, the
majority of participants reported preferring to undergo
future vaccinations using their baseline preference. This
should be explored further, including asking participants about their satisfaction with the procedure.
Fidelity of the intervention was demonstrated by
compliance of all but one participant with the instructions given by the nurse (i.e., >99% compliance). It was
anticipated that those who had initial preference to
look away and were randomized to look would find it
hard to be compliant with the instructions to look.
However, this was not the case in our study, at least
as measured by observable behavior.
Limitations of the study include the small sample size
and limited diversity in demographic of included participants (i.e., pharmacy students). Health care students,
in general, may have a higher tolerance for pain and fear
when it comes to vaccination due to a desensitization
effect from undergoing more routine vaccinations than
the average person.26 In addition, nurses, research personnel, and the participants were not blinded to the
study objective, which could have introduced bias.
Using an open design was considered acceptable because
there was no evidence suggesting that one way (i.e.,
looking at the needle or not looking at it) is better
than the other (i.e., bias was minimized by the lack of
perceived benefit of one condition over the other).
There are numerous strengths of the study. First, personal needle-looking preference was taken into account prior
to randomization. Second, the study used rigorous methodology, including randomization and allocation concealment. Third, the study procedures were standardized in
order to reduce performance and detection bias that may
have been introduced due to the open nature of this trial.
Finally, there were no dropouts, minimizing attrition bias.

Conclusion
This pilot study suggests that regardless of initial looking
preference or sex, telling adults to look away from the
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needle during vaccination can reduce fear. Alternatively,
clinicians can go by the individual’s preference, especially
accommodating those who have a strong preference to
look away. The results have implications for clinical practice. Simply telling individuals to look away from the
needle is an easy, free strategy that requires no training
and can help to reduce fear during vaccination. However,
given the preliminary nature of the results, we recommend caution interpreting these results and repeating the
study using a larger sample size and a different population
to further examine the relationship between looking preference and telling individuals to look at versus away from
the needle. This is particularly important for individuals
who declare a preference to look away and report higher
levels of fear. We also recommend further research for the
effect of this intervention during other needle procedures.
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